Medcaptain Medical Technology Co., Ltd. (HKG:2041)
8.78
-0.24 (-2.61%)
Sep 11, 2026, 4:08 PM HKT
HKG:2041 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Cash & Equivalents | 321.23 | 301.26 | 283.99 | 262.27 |
Short-Term Investments | - | - | 21.86 | 21.19 |
Trading Asset Securities | 157.38 | 145.22 | 132.49 | 156.11 |
Cash & Short-Term Investments | 478.61 | 446.48 | 438.34 | 439.56 |
Cash Growth | - | 1.86% | -0.28% | - |
Accounts Receivable | 170.52 | 168.23 | 133.07 | 104.78 |
Other Receivables | 19.49 | 26.69 | 14.91 | 12.57 |
Receivables | 190.01 | 194.92 | 147.98 | 117.35 |
Inventory | 253.82 | 263.44 | 230.21 | 236.96 |
Prepaid Expenses | - | 5.99 | - | - |
Other Current Assets | 42.58 | 25.41 | 32.3 | 28.22 |
Total Current Assets | 965.01 | 936.24 | 848.83 | 822.09 |
Property, Plant & Equipment | 534.17 | 537.67 | 481.54 | 398.18 |
Long-Term Investments | 0.65 | 0.65 | 0.65 | 7.95 |
Goodwill | 927.76 | 928.23 | 905.52 | 905.47 |
Other Intangible Assets | 499.28 | 515.14 | 550.17 | 597.43 |
Other Long-Term Assets | 14.53 | 13.16 | 18.26 | 24.44 |
Total Assets | 2,941 | 2,931 | 2,805 | 2,756 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Accounts Payable | 197.67 | 175.18 | 154.19 | 88.91 |
Accrued Expenses | 85.46 | 136.99 | 113.74 | 113.68 |
Short-Term Debt | 48 | 52.91 | 24.92 | 34.93 |
Current Portion of Long-Term Debt | 76.6 | 31.22 | 49.34 | 79.48 |
Current Portion of Leases | 18.62 | 22.9 | 19.97 | 26.95 |
Current Income Taxes Payable | 5.17 | 5.51 | 8.42 | 8.66 |
Current Unearned Revenue | 79.85 | 78.17 | 61.92 | 51.06 |
Other Current Liabilities | 75.89 | 76.55 | 110.16 | 93.13 |
Total Current Liabilities | 587.25 | 579.42 | 542.67 | 496.79 |
Long-Term Debt | 205.52 | 207.93 | 270.31 | 321.65 |
Long-Term Leases | 87.09 | 93.24 | 67.28 | 85.74 |
Long-Term Unearned Revenue | 104.31 | 107.28 | 98.41 | 67.28 |
Long-Term Deferred Tax Liabilities | 65.26 | 67.25 | 74.88 | 83.01 |
Other Long-Term Liabilities | - | - | 0.2 | 0.81 |
Total Liabilities | 1,049 | 1,055 | 1,054 | 1,055 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Common Stock | 499.72 | 499.72 | 499.72 | 476.62 |
Additional Paid-In Capital | 1,666 | 1,666 | 1,666 | 1,597 |
Retained Earnings | -994.12 | -991.02 | -1,040 | -939.08 |
Comprehensive Income & Other | 720.25 | 701.73 | 627.71 | 571.53 |
Total Common Equity | 1,892 | 1,876 | 1,754 | 1,706 |
Minority Interest | 0.11 | -0.47 | -2.32 | -5.52 |
Shareholders' Equity | 1,892 | 1,876 | 1,751 | 1,700 |
Total Liabilities & Equity | 2,941 | 2,931 | 2,805 | 2,756 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Total Debt | 435.82 | 408.19 | 431.82 | 548.75 |
Net Cash (Debt) | 42.79 | 38.29 | 6.52 | -109.19 |
Net Cash Growth | - | 487.63% | - | - |
Net Cash Per Share | 0.09 | 0.08 | - | - |
Filing Date Shares Outstanding | 499.72 | 499.72 | - | - |
Total Common Shares Outstanding | 499.72 | 499.72 | - | - |
Working Capital | 377.76 | 356.82 | 306.16 | 325.3 |
Book Value Per Share | 3.79 | 3.76 | - | - |
Tangible Book Value | 464.82 | 433.07 | 297.85 | 202.9 |
Tangible Book Value Per Share | 0.93 | 0.87 | - | - |
Buildings | 285.73 | 285.05 | 72.04 | 72.04 |
Machinery | 257.43 | 250.25 | 194.06 | 171.29 |
Construction In Progress | 11.81 | 5.22 | 186.14 | 65.66 |
Leasehold Improvements | 54.32 | 55.71 | 54.69 | 54.63 |